Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum Levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in Patients with Oral Cavity Cancer.

Literature DB >> 11173639

Serum Levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in Patients with Oral Cavity Cancer.

Ewa Jablonska¹, Leszek Piotrowski, Zyta Grabowska.

Abstract

Pro-inflammatory cytokines, such as interleukin-1b (IL-1b), interleukin-6 (IL-6) and tumor necrosis factor- (TNF-a) play an essential role in the regulation of immune response to, and may have prognostic significance in, cancer. The aim of this study was to examine the relationship between the serum levels of IL-1b, IL-6 and TNF-a as well as the concentrations of soluble TNF receptor I (sTNF-RI) and C-reactive protein (CRP) in patients with squamous cell carcinoma of oral cavity. Results obtained were confronted with squamous cell carcinoma antigen (SCC) concentrations. IL-1b IL-6 and TNF-a serum levels as well as sTNF-RI and CRP concentrations were higher in patients than in controls. The increased serum levels appeared to be related to the clinical stage of disease. There was a correlation between IL-1b and sTNF-RI. IL-6 and IL-1b correlated with CRP levels. The mean concentrations of SCC were also elevated. IL-6 and sTNF-RI seemed to be the most sensitive parameters in early stages and may be used as additional markers in oral cancer.

Entities: Disease Gene Species

Year: 1997 PMID： 11173639 DOI： 10.1007/bf02907807

Source DB: PubMed Journal: Pathol Oncol Res ISSN： 1219-4956 Impact factor: 3.201

21 in total

1. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Authors: D Aderka; J M Le; J Vilcek
Journal: J Immunol Date: 1989-12-01 Impact factor: 5.422

2. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.

Authors: Y Morinaga; H Suzuki; F Takatsuki; Y Akiyama; T Taniyama; K Matsushima; K Onozaki
Journal: J Immunol Date: 1989-12-01 Impact factor: 5.422

3. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.

Authors: R Schindler; J Mancilla; S Endres; R Ghorbani; S C Clark; C A Dinarello
Journal: Blood Date: 1990-01-01 Impact factor: 22.113

4. Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy.

Authors: E A Grosen; G A Granger; M Gatanaga; E K Ininns; C Hwang; P DiSaia; M Berman; A Manetta; D Emma; T Gatanaga
Journal: Gynecol Oncol Date: 1993-07 Impact factor: 5.482

5. Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy.

Authors: A Belldegrun; W Pierce; D Sayah; J deKernion; D Wallach; D Aderka; R A Figlin
Journal: J Immunother Emphasis Tumor Immunol Date: 1993-04

6. Concomitant measurements of interleukin-6 (IL-6) in serum and peritoneal fluid of patients with benign and malignant ovarian tumors.

Authors: W Schröder; C Ruppert; H G Bender
Journal: Eur J Obstet Gynecol Reprod Biol Date: 1994-07 Impact factor: 2.435

7. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

Authors: F T Cordingley; A Bianchi; A V Hoffbrand; J E Reittie; H E Heslop; A Vyakarnam; M Turner; A Meager; M K Brenner
Journal: Lancet Date: 1988-04-30 Impact factor: 79.321

8. Cytokine production and expression of adhesion molecules and integrins in tumor infiltrating lymphomononuclear cells of non-small cell carcinomas of the lung.

Authors: D Vitolo; M B Palmieri; L P Ruco; E Rendina; G Bonsignore; C D Baroni
Journal: Am J Pathol Date: 1994-08 Impact factor: 4.307

9. Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptors.

Authors: M Higuchi; B B Aggarwal
Journal: Biochem Biophys Res Commun Date: 1992-01-31 Impact factor: 3.575

10. Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.

Authors: E Tartour; T Dorval; V Mosseri; L Deneux; C Mathiot; H Brailly; F Montero; I Joyeux; P Pouillart; W H Fridman
Journal: Br J Cancer Date: 1994-05 Impact factor: 7.640

28 in total

1. Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors.

Authors: Jiaxiang Wang; Lei Wang; Da Zhang; Yuxia Fan; Zhankui Jia; Pan Qin; Jiekai Yu; Shu Zheng; Fuquan Yang
Journal: Mol Biol Rep Date: 2011-12-08 Impact factor: 2.316

2. Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma.

Authors: Eleftherios Vairaktaris; Christos Yapijakis; Zoe Serefoglou; Dimitrios Avgoustidis; Elena Critselis; Sofia Spyridonidou; Antonis Vylliotis; Spyridoula Derka; Stavros Vassiliou; Emeka Nkenke; Efstratios Patsouris
Journal: J Cancer Res Clin Oncol Date: 2008-02-14 Impact factor: 4.553

3. Association of Interleukin-10 (A1082G) gene polymorphism with Oral squamous cell carcinoma in north Indian population.

Authors: Syed Rizwan Hussain; Mohammad Kaleem Ahmad; Abbas Ali Mahdi; Hena Naqvi; Mohammad Waseem Ahmad; Saurabh Srivastava; Kumud Nigam; Shalini Gupta
Journal: J Genet Date: 2016-06 Impact factor: 1.166

4. Screening and identification of apolipoprotein A-I as a potential hepatoblastoma biomarker in children, excluding inflammatory factors.

Authors: Wei Zhao; Juan Li; Yilin Zhang; Pengfei Gao; Junjie Zhang; Fei Guo; Jiekai Yu; Shu Zheng; Jiaxiang Wang
Journal: Oncol Lett Date: 2015-05-14 Impact factor: 2.967

5. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression.

Authors: Zahra Mojtahedi; Bijan Khademi; Seyed Basir Hashemi; Seyed Mohammad Bagher Abtahi; Mohammad Ali Ghasemi; Mohammad Javad Fattahi; Abbas Ghaderi
Journal: Pathol Oncol Res Date: 2010-03-27 Impact factor: 3.201

6. Ultrasensitive microfluidic array for serum pro-inflammatory cytokines and C-reactive protein to assess oral mucositis risk in cancer patients.

Authors: Colleen E Krause; Brunah A Otieno; Gregory W Bishop; Gayatri Phadke; Linda Choquette; Rajesh V Lalla; Douglas E Peterson; James F Rusling
Journal: Anal Bioanal Chem Date: 2015-07-05 Impact factor: 4.142